Legislation was passed Thursday by House Democrats to lower prescription drug prices, the latest move in a lengthy health care debate. But the high-stakes showdown isn't over as the Republican-majority Senate is certain to ignore the Democrats' drug-pricing bill.
Sarepta Therapeutics' candidate Vyondys 53, or golodirsen, an injectable treatment developed to treat Duchenne muscular dystrophy, was granted accelerated approval by the FDA. The approval will require the company to conduct another trial that will confirm Vyondys 53's clinical benefit.
Miromatrix Medical is a startup focused on developing organs for potential transplantation into humans using discarded animal organs. Using biotechnology, a new organ is created in four to five weeks after what they call the "ghost" organ undergoes a process that involves dissolving the animal cells with a solution, being incubated, and then having human cells added with the use of a bioreactor.
A finalized proposal that would modernize the US' regulatory framework with regard to biotech crops may advance in 2020, according to officials of the US Department of Agriculture. "This is the first time in three decades that I think we are going to cross the finish line on updating plant biotechnology regulations," said Greg Ibach, USDA Undersecretary for marketing and regulatory programs at an annual stakeholder meeting of the USDA's Animal and Plant Health Inspection Service.
This year the toy brick company Lego released a new treehouse kit that was produced using a novel polyethylene created using sustainably sourced sugarcane. One of the challenges Lego faces is finding a material it can use to replace acrylonitrile butadiene styrene, which is a key material in the production of millions of Lego bricks sold each year.
Prescient Medicine and Erasmus MC have agreed to work together to study and assess LifeKit Predict, an opioid addiction risk technology, in the Netherlands. LifeKit uses multiplexed PCR and nucleic acid hybridization to analyze 16 genes in the brain's reward pathway.
Surgical automation, analytics and AI software technologies provider Caresyntax GmbH has pulled in $45.6 million in venture funding. It plans to use the proceeds to further development and commercialization of its products.
Oncology Pharma has signed a letter of intent to acquire at least a 50% stake of Diagnomics, which provides sequencing-based genomic testing services.
PerkinElmer has obtained marketing authorization from the FDA for its GSP Neonatal Creatine Kinase-MM kit for newborn screening for Duchenne muscular dystrophy. The test measures CK-MM protein concentration in newborns.